# Richtech Robotics Inc.: overview RR · Nasdaq · CIK 1963685 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/rr.md) · [Financials](/companies/rr/financials.md) · [Filings](/companies/rr/filings.md) · [Insiders](/companies/rr/insiders.md) Latest reported revenue: [$1.4m](/filings/0001213900-26-091798.md) for Q3 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 19, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-091798). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.5 d](/filings/0001213900-26-086751.md) | [1.3](/filings/0001213900-26-086761.md) | [1.2](/filings/0001213900-26-086762.md) | [1.2](/filings/0001213900-26-091798.md) | [1.4 d](/filings/0001213900-26-086751.md) | [1.1](/filings/0001213900-26-086761.md) | [1.5](/filings/0001213900-26-086762.md) | [1.4](/filings/0001213900-26-091798.md) | | Gross margin | % | [76.0% d](/filings/0001213900-26-086751.md) | [64.8%](/filings/0001213900-26-086761.md) | [31.3%](/filings/0001213900-26-086762.md) | [36.6%](/filings/0001213900-26-091798.md) | [13.9% d](/filings/0001213900-26-086751.md) | [2.8%](/filings/0001213900-26-086761.md) | [44.3%](/filings/0001213900-26-086762.md) | [58.4%](/filings/0001213900-26-091798.md) | | Operating margin | % | [(700.4%) d](/filings/0001213900-26-086751.md) | [(312.6%)](/filings/0001213900-26-086761.md) | [(435.5%)](/filings/0001213900-26-086762.md) | [(152.8%)](/filings/0001213900-26-091798.md) | [(442.5%) d](/filings/0001213900-26-086751.md) | [(1155.1%)](/filings/0001213900-26-086761.md) | [(335.4%)](/filings/0001213900-26-086762.md) | [(966.3%)](/filings/0001213900-26-091798.md) | | Net margin | % | [(675.8%) d](/filings/0001213900-26-015097.md) | [(2350.4%)](/filings/0001213900-26-086761.md) | [(47.6%)](/filings/0001213900-26-086762.md) | [(140.2%)](/filings/0001213900-26-091798.md) | [(581.9%) d](/filings/0001213900-26-015097.md) | [(947.2%)](/filings/0001213900-26-086761.md) | [(18.4%)](/filings/0001213900-26-086762.md) | [(726.9%)](/filings/0001213900-26-091798.md) | | Diluted EPS | $ per share | [(0.04)](/filings/0001213900-26-015097.md) | [(0.31)](/filings/0001213900-26-086761.md) | [0.00](/filings/0001213900-26-086762.md) | [(0.01)](/filings/0001213900-26-091798.md) | [(0.04)](/filings/0001213900-26-015097.md) | [(0.05)](/filings/0001213900-26-086761.md) | [0.00](/filings/0001213900-26-086762.md) | [(0.04)](/filings/0001213900-26-091798.md) | | Free cash flow | $m | not reported | [(2.5)](/filings/0001213900-26-086761.md) | [(2.8) d](/filings/0001213900-26-086762.md) | [(4.9) d](/filings/0001213900-26-091798.md) | [(3.8) d](/filings/0001213900-26-086751.md) | [(1.7)](/filings/0001213900-26-086761.md) | [(0.7) d](/filings/0001213900-26-086762.md) | [(23.0) d](/filings/0001213900-26-091798.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic; Revenue: us-gaap:Revenues; Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | [6.0](/filings/0001213900-24-026171.md) | [8.8](/filings/0001213900-25-019499.md) | [4.2](/filings/0001213900-26-086751.md) | [5.0](/filings/0001213900-26-086751.md) | | Gross margin | % | [65.3%](/filings/0001213900-24-026171.md) | [68.7%](/filings/0001213900-25-019499.md) | [63.7%](/filings/0001213900-26-086751.md) | [35.9%](/filings/0001213900-26-086751.md) | | Operating margin | % | [(6.2%)](/filings/0001213900-24-026171.md) | [3.3%](/filings/0001213900-25-019499.md) | [(183.5%)](/filings/0001213900-26-086751.md) | [(340.9%)](/filings/0001213900-26-086751.md) | | Net margin | % | [(8.4%)](/filings/0001213900-24-026171.md) | [(3.9%)](/filings/0001213900-25-019499.md) | [(32.3%)](/filings/0001213900-26-086751.md) | [(972.7%)](/filings/0001213900-26-086751.md) | | Diluted EPS | $ per share | [(0.01)](/filings/0001213900-24-026171.md) | [(0.01)](/filings/0001213900-25-019499.md) | [(0.02)](/filings/0001213900-26-086751.md) | [(0.40)](/filings/0001213900-26-086751.md) | | Free cash flow | $m | not reported | not reported | [(5.8)](/filings/0001213900-26-086751.md) | [(14.1)](/filings/0001213900-26-086751.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $32.0m | 15,177,129 | | Added +2,713,788 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $14.2m | 6,746,011 | | Added +3,935,598 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $13.9m | 6,576,161 | | Reduced −478,558 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $12.7m | 6,007,899 | | Added +1,465,296 | | [Davidson Kempner Capital Management LP](/funds/1595082.md) | 2026-06-30 | $10.6m | 5,000,000 | | Reduced −3,500,000 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $9.7m | 4,585,654 | | Added +701,428 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $6.5m | 3,067,710 | | Reduced −124,382 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $3.5m | 1,664,078 | | Added +766,126 | | [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $3.4m | 1,635,961 | | Added +115,306 | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $3.4m | 1,598,954 | | Reduced −248,822 | ## Recent filings [All 166 filings](/companies/rr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-02 | 21:25 ET | [8-K](/filings/0001213900-26-106552.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001213900-26-106552 | | 2026-09-21 | 12:00 ET | [8-K](/filings/0001213900-26-101655.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-101655 | | 2026-09-08 | 21:17 ET | [DEF 14A](/filings/0001213900-26-098112.md) | Proxy statement, period 2026-09-29 | 0001213900-26-098112 | | 2026-08-25 | 12:00 ET | [8-K](/filings/0001213900-26-093255.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-093255 | | 2026-08-19 | 21:30 ET | [10-Q](/filings/0001213900-26-091798.md) | Quarterly report, period 2026-06-30 | 0001213900-26-091798 | | 2026-08-07 | 20:54 ET | [10-Q](/filings/0001213900-26-086762.md) | Quarterly report, period 2026-03-31 | 0001213900-26-086762 | | 2026-08-07 | 20:53 ET | [10-Q/A](/filings/0001213900-26-086761.md) | Quarterly report, amended, period 2025-12-31 | 0001213900-26-086761 | | 2026-08-07 | 20:45 ET | [10-K/A](/filings/0001213900-26-086751.md) | Annual report, amended, period 2025-09-30 | 0001213900-26-086751 | | 2026-07-28 | 20:30 ET | [8-K](/filings/0001213900-26-082295.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-082295 | | 2026-06-12 | 01:35 ET | [8-K](/filings/0001213900-26-067978.md) | 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001213900-26-067978 | ## Latest annual report [Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001213900-26-005343.md), filed Jan 20, 2026. ## Forecast league Q4 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/c863eb31-aea6-4d71-b40f-6b992cf0daf4) ## About the filer - CIK: 1963685 - Tickers: RR - Exchange: Nasdaq - SIC code: 3569 General Industrial Machinery & Equipment, NEC - State of incorporation: NV - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.